Nordic Capital partners with Equashield, a leading global provider of hazardous drug compounding technologies
Nordic Capital has joined Equashield’s founders as a significant shareholder to support the Company’s next phase of growthEquashield announced today that Nordic Capital has joined the founders as a significant shareholder. Nordic Capital will support the acceleration of Equashield’s growth ambitions and the achievement of its strategic objective of global leadership in compounding technologies.
Equashield is a leading global provider of closed system transfer devices (CSTDs) designed to protect healthcare professionals from